查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2040079

冠狀動脈疾病藥物塗層球囊的全球市場：機會與策略展望（至2035年）

Drug-Coated Balloons For Coronary Artery Disease Global Market Opportunities And Strategies To 2035
出版日期: | 出版商: The Business Research Company | 英文 302 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

2020 年，全球冠狀動脈疾病藥物塗層球囊市場價值 2.478 億美元，預計到 2025 年將以超過 14.00% 的複合年成長率成長。

用於治療冠狀動脈疾病（CAD）的藥物塗層球囊（DCB）是一種心血管介入醫療設備，旨在透過經皮冠狀動脈介入治療（PCI）來治療狹窄或阻塞的冠狀動脈。 DCB在CAD治療中的主要目的是恢復受影響冠狀動脈的正常血流，同時最大限度地減少對支架等永久性植入的需求。

用於冠狀動脈疾病的藥物塗層球囊市場主要由營業單位（機構、自營或夥伴關係）銷售，這些球囊供介入性心臟科醫師在經皮冠狀動脈介入治療（PCI）手術中使用。 PCI手術通常在醫院、心臟導管檢查室進行，有時也會在門診手術中心進行。這些球囊用於球囊血管成形術，手術過程中，球囊經由導管導入，引導至病變部位，然後充氣擴張動脈，同時釋放藥物以防止血管再阻塞。

接觸吸煙和空氣污染的機會增加

從歷史上看，冠狀動脈疾病藥物塗層球囊市場的發展主要受吸煙和空氣污染加劇的影響。汽車廢氣、工業活動、住宅燃料燃燒和露天焚燒等來源排放的細懸浮微粒（PM2.5）濃度不斷上升，加上吸煙，已顯著增加了全球心血管疾病的風險。 PM2.5顆粒和香菸煙霧均含有足夠小的有害污染物，可以進入血液，引起發炎、內皮功能障礙和斑塊不穩定，最終增加冠狀動脈疾病的可能性。例如，美國肺臟協會（一個致力於改善肺部和心血管健康的全國性組織）於2024年6月發布了最新的菸草使用趨勢數據，顯示電子菸的使用顯著增加。 2014年至2022年間，使用過一次電子菸的成年人比例至少增加了56%，從12.6%上升至19.6%。同時，目前使用電子菸的成年人比例增加了62%，從3.7%增加到6.0%。此外，從2011年到2022年，國中生電子菸使用率成長了667%（從0.6%增加至4.6%），高中生電子煙使用率成長了567%（從1.5%增加到10.0%）。另外，2024年6月，由健康影響研究所（HEI）發起的獨立舉措「全球空氣狀況」（SoGA）發布了2023年PM2.5污染及其健康影響的最新數據。報告指出，2023年PM2.5暴露導致約490萬人死亡，使其成為全球主要的死亡風險因子。因此，冠狀動脈疾病藥物塗層球囊市場的成長是由吸菸和空氣污染暴露增加所驅動的。

Sirolimus洗脫藥物塗層球囊作為冠狀動脈介入治療的先進解決方案的興起。

冠狀動脈疾病藥物洗脫球囊市場的領導者正致力於研發Sirolimus洗脫藥物洗脫球囊（DCB），旨在加速血管癒合，並拓展新發病變和支架內再血管再阻塞的治療選擇。這些進展顯著改善了藥物釋放特性，降低了發炎反應，提高了手術柔軟性，同時為臨床醫生提供了符合不斷發展的介入治療策略的無植入解決方案。例如，2025年10月，總部位於美國的全球心血管器械製造商Cordis在TCT 2025大會上公佈了其Sirolimus洗脫球囊的最新臨床數據，重點介紹了其在大規模隨機試驗中對新發冠狀動脈疾病和支架內血管再阻塞患者的療效評估。報告的結果表明，該球囊的療效不劣於標準藥物釋放型支架治療，並顯示出有望使相當一部分患者免於永久性植入。該公司旨在透過利用先進的Sirolimus輸送技術和來自多中心臨床試驗的可靠證據，支持更廣泛地採用 DCB 解決方案，並滿足全球冠狀動脈介入治療市場不斷變化的需求。

用於治療冠狀動脈疾病的藥物塗層球囊的全球市場集中度很高，主要由幾家大型公司主導。截至2024年，排名前十的大型公司佔據了81.98%的市場。

目錄

第1章：執行摘要

第2章 目錄

第3章表格一覽

第4章：圖表一覽

第5章：報告結構

第6章 市場特徵

  • 市場的一般定義
  • 概述
  • 冠狀動脈疾病藥物塗層球囊市場：定義與細分
  • 市場區隔：依藥物類型
    • 紫杉醇塗層DCB
    • 輪圈塗層 DCB
  • 市場區隔：依最終用戶分類
    • 醫院
    • 心臟導管檢查室
    • 門診手術中心
    • 其他最終用戶

第7章：主要市場趨勢

  • Sirolimus洗脫藥物塗層球囊的出現，為冠狀動脈介入治療提供了先進的解決方案。
  • 擴大一項比較冠狀動脈介入治療中標準治療與藥物塗層球囊的臨床試驗
  • 用於治療更廣泛病變的下一代藥物塗層球囊（DCB）的進展

第 8 章：冠狀動脈疾病藥物塗層球囊臨床試驗管線分析（包括前 10 家公司的臨床階段和上市日期）

第9章：紫杉醇塗層藥物塗層球囊和利莫司塗層藥物塗層球囊臨床試驗的管線分析

第10章：冠狀動脈疾病藥物塗層球囊市場－宏觀經濟狀況

  • 利率波動的影響
  • 通膨壓力的影響
  • 地緣政治趨勢對供應鏈的影響
  • 新冠疫情的影響及恢復
  • 戰略洞察與未來展望

第11章：關稅戰與貿易保護主義對供應鏈的影響

第12章 全球冠狀動脈疾病藥物塗層球囊：成長分析與策略分析架構

  • 全球冠狀動脈疾病藥物塗層球囊市場：PESTEL 分析
  • 最終用戶（B2C）分析
    • 醫院
    • 心臟導管檢查室
    • 門診手術中心
    • 其他最終用戶
  • 全球冠狀動脈疾病藥物塗層球囊市場：成長率分析
  • 2020-2025年市場成長表現
    • 市場促進因素，2020-2025 年
    • 2020-2025年市場限制因素
  • 市場成長預測，2025-2030年，2035年
  • 預測的成長要素和促進因素
    • 定量成長要素
    • 抑制因子
  • 完全可及市場：冠狀動脈疾病藥物塗層球囊市場 - B2C
    • TAM比較分析

第13章：全球冠狀動脈疾病藥物塗層球囊：市場區隔

  • 依藥物類型
  • 最終用戶

第14章 2024年全球基於紫杉醇的藥物塗層球囊和基於雷帕黴素的藥物塗層球囊臨床試驗數量的估計

第15章：冠狀動脈疾病藥物塗層球囊市場：區域與國家分析

第16章 亞太市場

第17章 西歐市場

第18章：東歐市場

第19章：歐盟市場

第20章：北美市場

第21章：南美洲市場

第22章：拉丁美洲市場

第23章 中東市場

第24章：非洲市場

第25章：競爭格局與公司概況

  • 公司簡介
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co KG
  • Cordis Corporation（MedAlliance）
  • Meril Life Sciences Pvt. Ltd

第26章 其他大型企業和創新企業

  • Acotec Scientific Holdings., Ltd.
  • Medtronic plc
  • Blue Sail Medical
  • OrbusNeich Medical Company Ltd.
  • MicroPort Scientific Corporation
  • Acotec Scientific Holdings., Ltd.
  • Medtronic plc
  • Blue Sail Medical
  • OrbusNeich Medical Company Ltd.
  • MicroPort Scientific Corporation

第27章 競爭標桿分析

第28章：競爭對手儀錶板

第29章：冠狀動脈疾病藥物塗層球囊市場面臨的主要挑戰

第30章 重大併購

  • Teleflex Acquired Biotronik's Vascular Intervention business
  • Translumina Acquired Blue Medical Devices BV

第31章 近期趨勢：冠狀動脈疾病藥物塗層球囊市場

  • 透過 FDA核准的臨床試驗，擴大藥物塗層冠狀動脈球囊的使用範圍。

第32章：未來展望及潛在可能性分析

  • 2030年全球冠狀動脈疾病藥物塗層球囊市場：蘊藏新機會的國家
  • 2030年全球冠狀動脈疾病藥物塗層球囊市場：充滿新機會的細分市場
  • 2030年全球冠狀動脈疾病藥物塗層球囊市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第33章附錄

簡介目錄

Drug-coated balloons (DCBs) for coronary artery disease (CAD) refer to a category of interventional cardiovascular devices designed to treat narrowed or blocked coronary arteries through percutaneous coronary intervention (PCI). The primary purpose of DCBs in CAD treatment is to restore proper blood flow in diseased coronary arteries while minimizing the need for permanent implants like stents.

The drug-coated balloons for coronary artery disease market consists of sales, by entities (organizations, sole traders, or partnerships) that are used by interventional cardiologists and are deployed during PCI procedures commonly performed in hospitals, cardiac catheterization labs and, in some cases, ambulatory surgical centers. They are used at the time of balloon angioplasty, where the device is introduced via catheter, navigated to the lesion, inflated to dilate the artery and concurrently release the drug to prevent re-narrowing.

The global drug-coated balloons for coronary artery disease market was valued at $247.8 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 14.00%.

Higher Exposure To Smoking And Air Pollution

During the historic period, the drug-coated balloons for coronary artery disease market was driven by higher exposure to smoking and air pollution. Rising levels of fine particulate matter (PM2.5), emitted from vehicle exhaust, industrial activities, residential fuel combustion, and open burning, along with exposure to smoking, significantly elevate cardiovascular risk worldwide. Both PM2.5 particles and tobacco smoke contain harmful pollutants small enough to enter the bloodstream, triggering inflammation, endothelial dysfunction, and plaque instability, ultimately increasing the likelihood of developing coronary artery disease. For instance, in June 2024, the American Lung Association, a national organization dedicated to improving lung and cardiovascular health, released updated tobacco-use trend data highlighting significant increases in electronic cigarette usage. From 2014 to 2022, the proportion of adults who had ever used e-cigarettes rose by 56%, increasing from 12.6% to 19.6%, while adult current e-cigarette use grew by 62%, from 3.7% to 6.0%. Moreover, from 2011 to 2022, current use of e-cigarettes increased 667% among middle school students (from 0.6% to 4.6%) and 567% among high school students (from 1.5% to 10.0%). Additionally, in June 2024, the State of Global Air (SoGA), an independent initiative by the Health Effects Institute that provides global assessments of air pollution exposure and associated disease burden, published updated data on PM2.5 pollution and its health impacts for the year 2023, according to the report, PM2.5 exposure contributed to approximately 4.9 million deaths in 2023, making it one of the leading global risk factors for mortality. Therefore, the drug-coated balloons for coronary artery disease market was driven by higher exposure to smoking and air pollution.

Emergence Of Sirolimus-Eluting Drug-Coated Balloons As Advanced Solutions For Coronary Intervention

Major companies in the drug-coated balloons for coronary artery disease market are focusing on the development of sirolimus-eluting drug-coated balloons (DCBs) designed to provide enhanced vessel healing and broaden treatment options for both de novo lesions and in-stent restenosis. These advancements emphasize improved drug-release profiles, reduced inflammatory response and greater procedural flexibility, while offering clinicians implant-free solutions that align with evolving interventional strategies. For instance, in October 2025, Cordis, a US-based global cardiovascular device manufacturer, showcased new clinical data on its sirolimus-eluting balloon at the TCT 2025 conference, highlighting its performance in large, randomized studies evaluating outcomes in patients with both de novo coronary artery disease and in-stent restenosis. The reported results demonstrated non-inferiority to standard drug-eluting stent treatments, while also showing the potential to eliminate the need for permanent implants in a significant portion of patients. By utilizing advanced sirolimus-delivery technology and robust multi-trial clinical evidence, the company aims to support wider adoption of DCB solutions and to meet the evolving requirements of global coronary intervention markets.

The global drug-coated balloons for coronary artery disease market is highly concentrated, with large players operating in the market. The top 10 competitors in the market made up 81.98% of the total market in 2024.

Drug-Coated Balloons For Coronary Artery Disease Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global drug-coated balloons for coronary artery disease market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for drug-coated balloons for coronary artery disease ? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The drug-coated balloons for coronary artery disease market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider drug-coated balloons for coronary artery disease market; and compares it with other markets.

The report covers the following chapters

  • Introduction And Market Characteristics Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by component and by application.
  • Key Trends Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Global Market Size And Growth Global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
  • Market Segmentation Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by drug type and by end user in the market. Historic (2020-2025) and forecast (2025-2030) and (2020-2035) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments Information on recent developments in the market covered in the report.
  • Conclusions And Recommendations This section includes recommendations for drug-coated balloons for coronary artery disease providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Market Opportunities And Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Appendix This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Drug Type: Paclitaxel-Coated DCBs; Limus-Coated DCBs
  • 2) By End-User: Hospitals; Cardiac Catheterization Labs; Ambulatory Surgical Centers; Other End-Users
  • Companies Mentioned: B.Braun Melsungen AG; Boston Scientific Corporation; BIOTRONIK SE & Co. KG; Cordis Corporation (MedAlliance); Meril Life Sciences Pvt. Ltd.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; drug-coated balloons for coronary artery disease indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Drug-Coated Balloons For Coronary Artery Disease - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Drug-Coated Balloons For Coronary Artery Disease Market Definition And Segmentations
  • 6.4 Market Segmentation By Drug Type
    • 6.4.1 Paclitaxel-Coated DCBs
    • 6.4.2 Limus-Coated DCBs
  • 6.5 Market Segmentation By End User
    • 6.5.1 Hospitals
    • 6.5.2 Cardiac Catheterization Labs
    • 6.5.3 Ambulatory Surgical Centers
    • 6.5.4 Other End-Users

7 Major Market Trends

  • 7.1 Emergence Of Sirolimus-Eluting Drug-Coated Balloons As Advanced Solutions For Coronary Intervention
  • 7.2 Expansion Of Clinical Studies Evaluating Drug-Coated Balloons Against Standard Care In Coronary Interventions
  • 7.3 Advancement of Next-Generation Coronary Drug-Coated Balloons (DCBs) for Broader Lesion Treatment

8 Pipeline Analysis Section Covering Clinical Studies For Drug-Coated Balloons For Coronary Artery Disease Including Their Clinical Phase And Launch Time For The Top 10 Companies

9 Pipeline Analysis Section Covering Clinical Studies For Paclitaxel-Coated DCBs And Limus-Coated DCBs

10 Drug-Coated Balloons For Coronary Artery Disease Market - Macro Economic Scenario

  • 10.1 Impact of Interest Rate Fluctuations
  • 10.2 Impact of Inflationary Pressures
  • 10.3 Impact of Geopolitical Dynamics On Supply Chains
  • 10.4 Impact of the COVID-19 Pandemic And Recovery
  • 10.5 Strategic Insights And Future Outlook

11 Supply Chain Impact From Tariff War And Trade Protectionism

12 Global Drug-Coated Balloons For Coronary Artery Disease Growth Analysis And Strategic Analysis Framework

  • 12.1 Global Drug-Coated Balloons For Coronary Artery Disease PESTEL Analysis
    • 12.1.1 Political
    • 12.1.2 Economic
    • 12.1.3 Social
    • 12.1.4 Technological
    • 12.1.5 Environmental
    • 12.1.6 Legal
  • 12.2 Analysis Of End User (B2C)
    • 12.2.1 Hospitals
    • 12.2.2 Cardiac Catheterization Labs
    • 12.2.3 Ambulatory Surgical Centers
    • 12.2.4 Other End-Users
  • 12.3 Global Drug-Coated Balloons For Coronary Artery Disease Market Growth Rate Analysis
  • 12.4 Historic Market Growth, 2020 - 2025, Value ($ Million)
    • 12.4.1 Market Drivers 2020 - 2025
    • 12.4.2 Market Restraints 2020 - 2025
  • 12.5 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
  • 12.6 Forecast Growth Contributors/Factors
    • 12.6.1 Quantitative Growth Contributors
    • 12.6.2 Restraints
  • 12.7 Total Addressable Market for the Drug-Coated Balloons For Coronary Artery Disease Market - Business to Customer (B2C)
    • 12.7.1 TAM Comparison Analysis

13 Global Drug-Coated Balloons For Coronary Artery Disease Market Segmentation

  • 13.1 Global Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.2 Global Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.3 Global Drug-Coated Balloons For Coronary Artery Disease Market, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)
  • 13.4 Global Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)

14 Global Estimated Number Of Clinical Trails For Paclitaxel-Coated DCBs And Limus-Coated DCBs For 2024

15 Drug-Coated Balloons For Coronary Artery Disease Market, Regional and Country Analysis

  • 15.1 Global Drug-Coated Balloons For Coronary Artery Disease Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.2 Global Drug-Coated Balloons For Coronary Artery Disease Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 Asia-Pacific Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 Asia Pacific Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.4 Asia Pacific Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.5 Asia Pacific Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)
  • 16.6 Asia-Pacific Drug-Coated Balloons For Coronary Artery Disease Market: Country Analysis
  • 16.7 China Market
  • 16.8 Summary
  • 16.9 Market Overview
    • 16.9.1 Country Information
    • 16.9.2 Market Information
    • 16.9.3 Background Information
    • 16.9.4 Government Initiatives
    • 16.9.5 Regulations
    • 16.9.6 Regulatory Bodies
    • 16.9.7 Major Associations
    • 16.9.8 Taxes Levied
    • 16.9.9 Corporate Tax Structure
    • 16.9.10 Investments
    • 16.9.11 Major Companies
  • 16.10 China Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.11 China Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.12 China Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)
  • 16.13 India Market
  • 16.14 India Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.15 India Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.16 Japan Market
  • 16.17 Summary
  • 16.18 Market Overview
    • 16.18.1 Country Information
    • 16.18.2 Market Information
    • 16.18.3 Background Information
    • 16.18.4 Government Initiatives
    • 16.18.5 Regulations
    • 16.18.6 Regulatory Bodies
    • 16.18.7 Major Associations
    • 16.18.8 Taxes Levied
    • 16.18.9 Corporate Tax Structure
    • 16.18.10 Investments
    • 16.18.11 Major Companies
  • 16.19 Japan Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.20 Japan Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.21 Japan Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)
  • 16.22 Australia Market
  • 16.23 Australia Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.24 Australia Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.25 Indonesia Market
  • 16.26 Indonesia Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.27 Indonesia Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.28 South Korea Market
  • 16.29 Summary
  • 16.30 Market Overview
    • 16.30.1 Country Information
    • 16.30.2 Market Information
    • 16.30.3 Background Information
    • 16.30.4 Government Initiatives
    • 16.30.5 Regulations
    • 16.30.6 Regulatory Bodies
    • 16.30.7 Major Associations
    • 16.30.8 Taxes Levied
    • 16.30.9 Corporate Tax Structure
    • 16.30.10 Investments
    • 16.30.11 Major Companies
  • 16.31 South Korea Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.32 South Korea Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 Western Europe Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate tax structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Western Europe Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.4 Western Europe Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.5 Western Europe Drug-Coated Balloons For Coronary Artery Disease Market: Country Analysis
  • 17.6 UK Market
  • 17.7 UK Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.8 UK Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.9 Germany Market
  • 17.10 Germany Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.11 Germany Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.12 France Market
  • 17.13 France Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.14 France Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.15 Italy Market
  • 17.16 Italy Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.17 Italy Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.18 Spain Market
  • 17.19 Spain Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.20 Spain Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 Eastern Europe Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Major companies
  • 18.3 Eastern Europe Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.4 Eastern Europe Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.5 Eastern Europe Drug-Coated Balloons For Coronary Artery Disease Market: Country Analysis
  • 18.6 Russia Market
  • 18.7 Russia Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.8 Russia Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

19 European Union (EU) Market

  • 19.1 European Union (EU) Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.2 European Union (EU) Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.3 European Union (EU) Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)

20 North America Market

  • 20.1 Summary
  • 20.2 Market Overview
    • 20.2.1 Region Information
    • 20.2.2 Market Information
    • 20.2.3 Background Information
    • 20.2.4 Government Initiatives
    • 20.2.5 Regulations
    • 20.2.6 Regulatory Bodies
    • 20.2.7 Major Associations
    • 20.2.8 Taxes Levied
    • 20.2.9 Corporate Tax Structure
    • 20.2.10 Investments
    • 20.2.11 Major Companies
  • 20.3 North America Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.4 North America Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.5 North America Drug-Coated Balloons For Coronary Artery Disease Market: Country Analysis
  • 20.6 USA Market
  • 20.7 Summary
  • 20.8 Market Overview
    • 20.8.1 Country Information
    • 20.8.2 Market Information
    • 20.8.3 Background Information
    • 20.8.4 Government Initiatives
    • 20.8.5 Regulations
    • 20.8.6 Regulatory Bodies
    • 20.8.7 Major Associations
    • 20.8.8 Taxes Levied
    • 20.8.9 Corporate Tax Structure
    • 20.8.10 Investments
    • 20.8.11 Major Companies
  • 20.9 USA Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.10 USA Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.11 USA Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)
  • 20.12 Canada Market
  • 20.13 Summary
  • 20.14 Market Overview
    • 20.14.1 Country Information
    • 20.14.2 Market Information
    • 20.14.3 Background Information
    • 20.14.4 Government Initiatives
    • 20.14.5 Regulations
    • 20.14.6 Regulatory Bodies
    • 20.14.7 Major Associations
    • 20.14.8 Taxes Levied
    • 20.14.9 Corporate Tax Structure
    • 20.14.10 Major Companies
  • 20.15 Canada Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.16 Canada Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.17 Canada Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)

21 South America Market

  • 21.1 Summary
  • 21.2 Market Overview
    • 21.2.1 Region Information
    • 21.2.2 Market Information
    • 21.2.3 Background Information
    • 21.2.4 Government Initiatives
    • 21.2.5 Regulations
    • 21.2.6 Regulatory Bodies
    • 21.2.7 Major Associations
    • 21.2.8 Taxes Levied
    • 21.2.9 Corporate Tax Structure
    • 21.2.10 Investments
    • 21.2.11 Major Companies
  • 21.3 South America Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.4 South America Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.5 Brazil Market
  • 21.6 Brazil Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.7 Brazil Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

22 Latin America Market

  • 22.1 Latin America Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 22.2 Latin America Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 22.3 Latin America Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Volume (Number)

23 Middle East Market

  • 23.1 Summary
  • 23.2 Market Overview
    • 23.2.1 Region Information
    • 23.2.2 Market Information
    • 23.2.3 Background Information
    • 23.2.4 Government Initiatives
    • 23.2.5 Regulations
    • 23.2.6 Regulatory Bodies
    • 23.2.7 Major Associations
    • 23.2.8 Taxes Levied
    • 23.2.9 Corporate Tax Structure
    • 23.2.10 Major Companies
  • 23.3 Middle East Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 23.4 Middle East Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

24 Africa Market

  • 24.1 Summary
  • 24.2 Market Overview
    • 24.2.1 Region Information
    • 24.2.2 Market Information
    • 24.2.3 Background Information
    • 24.2.4 Government Initiatives
    • 24.2.5 Regulations
    • 24.2.6 Regulatory Bodies
    • 24.2.7 Major Associations
    • 24.2.8 Taxes Levied
    • 24.2.9 Corporate Tax Structure
    • 24.2.10 Major Companies
  • 24.3 Africa Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By Drug Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 24.4 Africa Drug-Coated Balloons For Coronary Artery Disease Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

25 Competitive Landscape And Company Profiles

  • 25.1 Company Profiles
  • 25.2 B. Braun Melsungen AG
    • 25.2.1 Company Overview
    • 25.2.2 Products And Services
    • 25.2.3 Business Strategy
    • 25.2.4 Financial Overview
  • 25.3 Boston Scientific Corporation
    • 25.3.1 Company Overview
    • 25.3.2 Products And Services
    • 25.3.3 Business Strategy
    • 25.3.4 Financial Overview
  • 25.4 BIOTRONIK SE & Co KG
    • 25.4.1 Company Overview
    • 25.4.2 Products And Services
    • 25.4.3 Business Strategy
    • 25.4.4 Financial Overview
  • 25.5 Cordis Corporation (MedAlliance)
    • 25.5.1 Company Overview
    • 25.5.2 Products And Services
    • 25.5.3 Financial Overview
  • 25.6 Meril Life Sciences Pvt. Ltd
    • 25.6.1 Company Overview
    • 25.6.2 Products And Services
    • 25.6.3 Financial Overview

26 Other Major And Innovative Companies

  • 26.1 Acotec Scientific Holdings., Ltd.
    • 26.1.1 Company Overview
    • 26.1.2 Products And Services
  • 26.2 Medtronic plc
    • 26.2.1 Company Overview
    • 26.2.2 Products And Services
  • 26.3 Blue Sail Medical
    • 26.3.1 Company Overview
    • 26.3.2 Products And Services
  • 26.4 OrbusNeich Medical Company Ltd.
    • 26.4.1 Company Overview
    • 26.4.2 Products And Services
  • 26.5 MicroPort Scientific Corporation
    • 26.5.1 Company Overview
    • 26.5.2 Products And Services
  • 26.6 Acotec Scientific Holdings., Ltd.
    • 26.6.1 Company Overview
    • 26.6.2 Products And Services
  • 26.7 Medtronic plc
    • 26.7.1 Company Overview
    • 26.7.2 Products And Services
  • 26.8 Blue Sail Medical
    • 26.8.1 Company Overview
    • 26.8.2 Products And Services
  • 26.9 OrbusNeich Medical Company Ltd.
    • 26.9.1 Company Overview
    • 26.9.2 Products And Services
  • 26.10 MicroPort Scientific Corporation
    • 26.10.1 Company Overview
    • 26.10.2 Products And Services

27 Competitive Benchmarking

28 Competitive Dashboard

29 Key Challenges in Drug-Coated Balloons For The Coronary Artery Disease Market

30 Key Mergers And Acquisitions

  • 30.1 Teleflex Acquired Biotronik's Vascular Intervention business
  • 30.2 Translumina Acquired Blue Medical Devices BV

31 Recent Developments In Drug-Coated Balloons For Coronary Artery Disease

  • 31.1 Expansion Of Coronary Drug-Coated Balloon Use Through FDA-Approved Clinical Investigations

32 Future Outlook and Potential Analysis

  • 32.1 Global Drug-Coated Balloons For Coronary Artery Disease Market In 2030 - Countries Offering Most New Opportunities
  • 32.2 Global Drug-Coated Balloons For Coronary Artery Disease Market In 2030 - Segments Offering Most New Opportunities
  • 32.3 Global Drug-Coated Balloons For Coronary Artery Disease Market In 2030 - Growth Strategies
    • 32.3.1 Market Trend Based Strategies
    • 32.3.2 Competitor Strategies

33 Appendix

  • 33.1 Geographies Covered
  • 33.2 Market Data Sources
  • 33.3 Research Methodology
  • 33.4 Currencies
  • 33.5 The Business Research Company
  • 33.6 Copyright and Disclaimer